5% glucose/0.9% sodium chloride injection

5% glucose/0.9% sodium chloride injection
SPL v3
SPL
SPL Set ID 1ba918d0-13d0-48bc-8742-658fc0eb47b6
Route
intravenous
Published
Effective Date 2024-11-21
Document Type 34391-3 HUMAN PRESCRIPTION DRUG LABEL

Drug Facts

Composition & Product

Active Ingredients
anhydrous dextrose (5.5 g) chloride ion (0.9 g)
Inactive Ingredients
water

Identifiers & Packaging

Marketing Status
unapproved drug for use in drug shortage active Since 2024-10-11

Description

Reporting Adverse Events or Product Quality Issues To report adverse events associated with these imported products, please call Baxter at 1-866-888-2472, or fax: 1- 800-759-1801. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax: • Complete and submit the report Online : www.fda.gov/medwatch/report.htm • Regular mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. To report product quality issues associated with these imported products, please contact Baxter Product Surveillance through Baxter - Product Feedback Portal ( https://productfeedback.baxter.com/ ). Please also refer to the local prescribing information of the imported product, translated into English, available for: • 0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723233 ) • 5% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723235 ) • 10% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723237 ) • 5% Glucose/0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723238 ) Please refer to the FDA-approved prescribing information for each drug product listed below: • 0.9% Sodium Chloride Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&type=pdf&name=f55bd888-5e01-474d-871b-24654c070178 ) • 5% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 ) • 10% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 ) • 5% Dextrose/0.9% Sodium Chloride Injection USP (click https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf )


Medication Information

Description

Reporting Adverse Events or Product Quality Issues To report adverse events associated with these imported products, please call Baxter at 1-866-888-2472, or fax: 1- 800-759-1801. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax: • Complete and submit the report Online : www.fda.gov/medwatch/report.htm • Regular mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178. To report product quality issues associated with these imported products, please contact Baxter Product Surveillance through Baxter - Product Feedback Portal ( https://productfeedback.baxter.com/ ). Please also refer to the local prescribing information of the imported product, translated into English, available for: • 0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723233 ) • 5% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723235 ) • 10% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723237 ) • 5% Glucose/0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723238 ) Please refer to the FDA-approved prescribing information for each drug product listed below: • 0.9% Sodium Chloride Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&type=pdf&name=f55bd888-5e01-474d-871b-24654c070178 ) • 5% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 ) • 10% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5 ) • 5% Dextrose/0.9% Sodium Chloride Injection USP (click https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf )

Package Insert
Health Care Professional Letter

Reporting Adverse Events or Product Quality Issues

To report adverse events associated with these imported products, please call Baxter at 1-866-888-2472, or fax: 1- 800-759-1801. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm

Regular mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

To report product quality issues associated with these imported products, please contact Baxter Product Surveillance through Baxter - Product Feedback Portal (https://productfeedback.baxter.com/).

Please also refer to the local prescribing information of the imported product, translated into English, available for:

• 0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723233)

• 5% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723235)

• 10% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723237)

• 5% Glucose/0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723238)

Please refer to the FDA-approved prescribing information for each drug product listed below:

• 0.9% Sodium Chloride Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&type=pdf&name=f55bd888-5e01-474d-871b-24654c070178)

• 5% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)

• 10% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)

• 5% Dextrose/0.9% Sodium Chloride Injection USP (click https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf)

Package/label Principal Display Panel

Baxter Logo Trademark

A6C1064US

GLUCOSE AND

SODIUM CHLORIDE INJECTION

100

200

300

400

500

600

700

800

900

1000ml

5% GLUCOSE

0.9% SODIUM CHLORIDE

[Strength] 1000ml: glucose 50g

and sodium chloride 9g

[Description] This product is a clear, colorless liquid

[Dosage and Administration] Intravenous drip   See the

package insert for details 

For details of [Indications], [Adverse Reactions],

[Contraindications], and [Precautions], please refer to the

package insert

[Storage] Store in overwrap

The solution should be clear and should be used

up at one time

Inspect the inner bag by squeezing it and discard 

solution if leakage occurs

License Number: H19994068

AA

[Drug Marketing Authorization Holder] [Manufacturer]

Name: Baxter Healthcare (Shanghai) Co., Ltd.

Address: No. 388, Tingzhu Road, Jinshan District, Shanghai

BarCode

(01) 00303389799016

LOT

MFG

EXP

5% Glucose/0.9% Sodium Chloride Injection

1000ml X 12

LOT S0000000 EXP YYYY-MM

A6C1064US 1C/N LIC H19994068

5% Glucose/0.9% Sodium Chloride Injection

1000ml X 12

LOT S0000000 EXP YYYY-MM

MFG YYYY-MM-DD 1C/N 0000


Structured Label Content

Package Insert (PACKAGE INSERT)
Health Care Professional Letter (HEALTH CARE PROFESSIONAL LETTER)

Reporting Adverse Events or Product Quality Issues

To report adverse events associated with these imported products, please call Baxter at 1-866-888-2472, or fax: 1- 800-759-1801. Adverse events or quality problems experienced with the use of these imported products may also be reported to the FDA's MedWatch Adverse Event Reporting program either online, by regular mail or by fax:

• Complete and submit the report Online: www.fda.gov/medwatch/report.htm

Regular mail or Fax: Download form www.fda.gov/MedWatch/getforms.htm or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.

To report product quality issues associated with these imported products, please contact Baxter Product Surveillance through Baxter - Product Feedback Portal (https://productfeedback.baxter.com/).

Please also refer to the local prescribing information of the imported product, translated into English, available for:

• 0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723233)

• 5% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723235)

• 10% Glucose Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723237)

• 5% Glucose/0.9% Sodium Chloride Injection (click https://nctr-crs.fda.gov/fdalabel/ui/spl-summaries/criteria/723238)

Please refer to the FDA-approved prescribing information for each drug product listed below:

• 0.9% Sodium Chloride Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=f55bd888-5e01-474d-871b-24654c070178&type=pdf&name=f55bd888-5e01-474d-871b-24654c070178)

• 5% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)

• 10% Dextrose Injection USP (click https://www.dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5&type=pdf&name=3bb406a9-f5cb-403a-b1bb-5c4facbea3d5)

• 5% Dextrose/0.9% Sodium Chloride Injection USP (click https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/016678s007,016683s103,016687s104,016689s107,016697s098lbl.pdf)

Package/label Principal Display Panel (PACKAGE/LABEL PRINCIPAL DISPLAY PANEL)

Baxter Logo Trademark

A6C1064US

GLUCOSE AND

SODIUM CHLORIDE INJECTION

100

200

300

400

500

600

700

800

900

1000ml

5% GLUCOSE

0.9% SODIUM CHLORIDE

[Strength] 1000ml: glucose 50g

and sodium chloride 9g

[Description] This product is a clear, colorless liquid

[Dosage and Administration] Intravenous drip   See the

package insert for details 

For details of [Indications], [Adverse Reactions],

[Contraindications], and [Precautions], please refer to the

package insert

[Storage] Store in overwrap

The solution should be clear and should be used

up at one time

Inspect the inner bag by squeezing it and discard 

solution if leakage occurs

License Number: H19994068

AA

[Drug Marketing Authorization Holder] [Manufacturer]

Name: Baxter Healthcare (Shanghai) Co., Ltd.

Address: No. 388, Tingzhu Road, Jinshan District, Shanghai

BarCode

(01) 00303389799016

LOT

MFG

EXP

5% Glucose/0.9% Sodium Chloride Injection

1000ml X 12

LOT S0000000 EXP YYYY-MM

A6C1064US 1C/N LIC H19994068

5% Glucose/0.9% Sodium Chloride Injection

1000ml X 12

LOT S0000000 EXP YYYY-MM

MFG YYYY-MM-DD 1C/N 0000


Advanced Ingredient Data


Raw Label Data

All Sections (JSON)